The BioZorb 3-D surgical marker improves visualization of the treatment area for radiation planning and therapy, according to a presentation at the San Antonio Breast Cancer Symposium 2013.

Lexmark’s Perceptive Software announced that its Acuo vendor neutral archive (VNA) platform was ranked by MarketsandMarkets, global market research and consulting company, as the world market share leader.

nuclear imaging spect spect/ct IMV

A report released by IMV Medical Information Division found that providers of nuclear medicine (NM) services are consolidating as procedure volume dropped in the subspecialty from 2008 to 2012. 

A study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently recommended for people considered at low risk, should play a more prominent role in helping determine a person’s risk for heart attack and heart disease-related death, as well as the need for angioplasty or bypass surgery.
proton therapy radiation therapy mevion s250

A patient with a rare type of cancer (chondrosarcoma) at the base of the skull has become the first person in the world to receive proton therapy using the Mevion S250 proton therapy system from Mevion Medical Systems Inc. of Littleton, Mass.

GE Healthcare showcased at the Radiological Society of North America Annual Meeting (RSNA 2013) a work-in-progress product for positron emission tomography (PET) that quickly and confidently evaluates a patient’s response to cancer treatment.

 Intelerad Medical Systems, a medical imaging picture archiving and communication systems (PACS), radiology information systems (RIS) and workflow solutions company, announced the launch of InteleRIS 8.224, the latest version of its reporting information system.

Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the process of diagnosing breast cancer, today announced preliminary information from a feasibility study of its Imagio breast imaging device. Results from the feasibility study suggest that information from Imagio, beyond that available from traditional breast ultrasound, may be helpful in assisting physicians in their decisions whether to recommend biopsies for women with suspicious breast masses. The data were presented at the annual meeting of the Radiological Society of America (RSNA).

The American College of Radiology (ACR) strongly supports the Excellence in Diagnostic Imaging Utilization Act of 2013 (H.R. 3705), which would require ordering physicians to  consult physician-developed appropriateness criteria when ordering advanced diagnostic imaging studies for Medicare patients. This ACR backed bipartisan bill is separate from, and in addition to, a similar appropriateness criteria policy included in the SGR Repeal and Medicare Beneficiary Access Act of 2013, currently under debate in the House and Senate. Congress will likely consider these bills in early 2014.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now